Skip to main content
Premium Trial:

Request an Annual Quote

Motorola Launches First Bioarray; More Set to Follow Through January

NEW YORK, Aug. 15 – Motorola Life Sciences introduced its high-density human genome bioarray on Wednesday as part of its CodeLink bioarray systems launch.

The introduction, made at the Drug Discovery Technology 2001 conference in Boston, launches Motorola’s Uniset Human I bioarray, which the company said includes approximately 9,200 unique oligonucleotides representing human EST clusters. 

The bioarray content comes from sequences in the public UniGene database that was compared and confirmed against Incyte’s LifeSeq database, Scott Magnuson, Motorola Life Sciences’ head of genomics and bioinformatics, told GenomeWeb .

The launch marks the first in a series of bioarrays that Motorola has scheduled to unveil over the next five months, according to Mike James, vice president of commercial operations at Motorola Life Sciences. 

These products include a 10K rat genome bioarray, which is slated to appear in September; a Uniset II human array that features additional UniGene data plus data from Incyte, scheduled to be introduced around the end of the year; and an array designed to measure SNPs within the P450 gene family, which will launch at year’s end.

All of the bioarrays are designed around Motorola’s new CodeLink software and database platform. 

The Uniset Human I bioarray is targeted at researchers already using pre-fabricated arrays in addition to researchers who self-spot, said Bill Coty, Motorola Life Sciences’ director of product development.  

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.